Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice
- PMID: 18840266
- PMCID: PMC2567326
- DOI: 10.1186/1471-2458-8-350
Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice
Abstract
Background: To assess the feasibility and uptake of a diabetes screening programme; to examine the effects of invitation to diabetes screening on anxiety, self-rated health and illness perceptions.
Methods: Randomised controlled trial in two general practices in Cambridgeshire. Individuals aged 40-69 without known diabetes were identified as being at high risk of having undiagnosed type 2 diabetes using patient records and a validated risk score (n = 1,280). 355 individuals were randomised in a 2 to 1 ratio into non-invited (n = 238) and invited (n = 116) groups. A stepwise screening programme confirmed the presence or absence of diabetes. Six weeks after the last contact (either test or invitation), a questionnaire was sent to all participants, including non-attenders and those who were not originally invited. Outcome measures included attendance, anxiety (short-form Spielberger State Anxiety Inventory-STAI), self-rated health and diabetes illness perceptions.
Results: 95 people (82% of those invited) attended for the initial capillary blood test. Six individuals were diagnosed with diabetes. Invited participants were more anxious than those not invited (37.6 vs. 34.1 STAI, p-value = 0.015), and those diagnosed with diabetes were considerably more anxious than those classified free of diabetes (46.7 vs. 37.0 STAI, p-value = 0.031). Non-attenders had a higher mean treatment control sub-scale (3.87 vs. 3.56, p-value = 0.016) and a lower mean emotional representation sub-scale (1.81 vs. 2.68, p-value = 0.001) than attenders. No differences in the other five illness perception sub-scales or self-rated health were found.
Conclusion: Screening for type 2 diabetes in primary care is feasible but may be associated with higher levels of short-term anxiety among invited compared with non-invited participants.
Figures
Similar articles
-
Screening for Prediabetes and Type 2 Diabetes Mellitus: An Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Aug. Report No.: 21-05276-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Aug. Report No.: 21-05276-EF-1. PMID: 34554661 Free Books & Documents. Review.
-
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial.BMJ. 2010 May 13;340:c2138. doi: 10.1136/bmj.c2138. BMJ. 2010. PMID: 20466791 Free PMC article. Clinical Trial.
-
A randomized evaluation of loss and gain frames in an invitation to screening for type 2 diabetes: effects on attendance, anxiety and self-rated health.J Health Psychol. 2010 Mar;15(2):196-204. doi: 10.1177/1359105309344896. J Health Psychol. 2010. PMID: 20207663 Clinical Trial.
-
Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial.BMJ. 2007 Sep 8;335(7618):486. doi: 10.1136/bmj.39303.723449.55. Epub 2007 Aug 30. BMJ. 2007. PMID: 17761995 Free PMC article. Clinical Trial.
Cited by
-
Recurrent SARS-CoV-2 Serology Testing and Pandemic Anxiety: A Study of Pediatric Healthcare Workers.Int J Environ Res Public Health. 2022 Aug 3;19(15):9562. doi: 10.3390/ijerph19159562. Int J Environ Res Public Health. 2022. PMID: 35954913 Free PMC article.
-
Screening for Diabetes and Prediabetes.Endocrinol Metab Clin North Am. 2021 Sep;50(3):369-385. doi: 10.1016/j.ecl.2021.05.002. Epub 2021 Jul 12. Endocrinol Metab Clin North Am. 2021. PMID: 34399951 Free PMC article. Review.
-
Cultural adaptation and psychometric evaluation of the Kinyarwanda version of the problem areas in diabetes (PAID) questionnaire.Health Qual Life Outcomes. 2021 Jul 22;19(1):183. doi: 10.1186/s12955-021-01821-w. Health Qual Life Outcomes. 2021. PMID: 34294101 Free PMC article.
-
Screening for type 2 diabetes mellitus.Cochrane Database Syst Rev. 2020 May 29;5(5):CD005266. doi: 10.1002/14651858.CD005266.pub2. Cochrane Database Syst Rev. 2020. PMID: 32470201 Free PMC article.
-
Short-term mental distress in research participants after receiving cardiovascular risk information.PLoS One. 2019 May 24;14(5):e0217247. doi: 10.1371/journal.pone.0217247. eCollection 2019. PLoS One. 2019. PMID: 31125371 Free PMC article.
References
-
- Genuth SM, Houser HB, Carter JR, Jr, Merkatz IR, Price JW, Schumacher OP, Wieland RG. Observations on the value of mass indiscriminate screening for diabetes mellitus based on a five-year follow-up. Diabetes. 1978;27:377–383. - PubMed